ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Necrotic Enteritis Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5G14580
Home | Market Reports | Health| Health Conditions
Global Necrotic Enteritis Treatment Market Research Report 2023
BUY CHAPTERS

Global Necrotic Enteritis Treatment Market Research Report 2025

Code: QYRE-Auto-5G14580
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ProMetic Life Sciences Inc
BioGaia Probiotics
Fresenius Kabi AG
Actavis
Bayer International
Alcon Laboratories， Inc
Bausch& Lomb Incorporated
GlaxoSmithKline PLC
Pfizer Inc
Transo-Pharm
Rochem International
HELM Portugal

Necrotic Enteritis Treatment Market Size

The global market for Necrotic Enteritis Treatment was valued at US$ 28440 million in the year 2024 and is projected to reach a revised size of US$ 45360 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Necrotic Enteritis Treatment Market

Necrotic Enteritis Treatment Market

Necrotic enteritis is an enteric disease of poultry characterized by patches of necrotic tissue on the intestinal epithelium. This disease can cause high mortality, primarily in juvenile broilers.
North American market for Necrotic Enteritis Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Necrotic Enteritis Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Necrotic Enteritis Treatment include Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc., Pfizer, Transo-Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Necrotic Enteritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Necrotic Enteritis Treatment.
The Necrotic Enteritis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Necrotic Enteritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Necrotic Enteritis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Necrotic Enteritis Treatment Market Report

Report Metric Details
Report Name Necrotic Enteritis Treatment Market
Accounted market size in year US$ 28440 million
Forecasted market size in 2031 US$ 45360 million
CAGR 7.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Home
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc., Pfizer, Transo-Pharm, Rochem International, HELM Portugal
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Necrotic Enteritis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Necrotic Enteritis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Necrotic Enteritis Treatment Market growing?

Ans: The Necrotic Enteritis Treatment Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Necrotic Enteritis Treatment Market size in 2031?

Ans: The Necrotic Enteritis Treatment Market size in 2031 will be US$ 45360 million.

Who are the main players in the Necrotic Enteritis Treatment Market report?

Ans: The main players in the Necrotic Enteritis Treatment Market are Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc., Pfizer, Transo-Pharm, Rochem International, HELM Portugal

What are the Application segmentation covered in the Necrotic Enteritis Treatment Market report?

Ans: The Applications covered in the Necrotic Enteritis Treatment Market report are Hospital, Clinic, Home

What are the Type segmentation covered in the Necrotic Enteritis Treatment Market report?

Ans: The Types covered in the Necrotic Enteritis Treatment Market report are Oral, Parenteral

Recommended Reports

Poultry & Enteric Disease

Intestinal & GI Therapeutics

Infectious & Sepsis Therapy

1 Necrotic Enteritis Treatment Market Overview
1.1 Product Definition
1.2 Necrotic Enteritis Treatment by Type
1.2.1 Global Necrotic Enteritis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Parenteral
1.3 Necrotic Enteritis Treatment by Application
1.3.1 Global Necrotic Enteritis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Global Necrotic Enteritis Treatment Market Size Estimates and Forecasts
1.4.1 Global Necrotic Enteritis Treatment Revenue 2020-2031
1.4.2 Global Necrotic Enteritis Treatment Sales 2020-2031
1.4.3 Global Necrotic Enteritis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Necrotic Enteritis Treatment Market Competition by Manufacturers
2.1 Global Necrotic Enteritis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Necrotic Enteritis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Necrotic Enteritis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Necrotic Enteritis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Necrotic Enteritis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Necrotic Enteritis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Necrotic Enteritis Treatment, Date of Enter into This Industry
2.8 Global Necrotic Enteritis Treatment Market Competitive Situation and Trends
2.8.1 Global Necrotic Enteritis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Necrotic Enteritis Treatment Players Market Share by Revenue
2.8.3 Global Necrotic Enteritis Treatment Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Necrotic Enteritis Treatment Market Scenario by Region
3.1 Global Necrotic Enteritis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Necrotic Enteritis Treatment Sales by Region: 2020-2031
3.2.1 Global Necrotic Enteritis Treatment Sales by Region: 2020-2025
3.2.2 Global Necrotic Enteritis Treatment Sales by Region: 2026-2031
3.3 Global Necrotic Enteritis Treatment Revenue by Region: 2020-2031
3.3.1 Global Necrotic Enteritis Treatment Revenue by Region: 2020-2025
3.3.2 Global Necrotic Enteritis Treatment Revenue by Region: 2026-2031
3.4 North America Necrotic Enteritis Treatment Market Facts & Figures by Country
3.4.1 North America Necrotic Enteritis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Necrotic Enteritis Treatment Sales by Country (2020-2031)
3.4.3 North America Necrotic Enteritis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Necrotic Enteritis Treatment Market Facts & Figures by Country
3.5.1 Europe Necrotic Enteritis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Necrotic Enteritis Treatment Sales by Country (2020-2031)
3.5.3 Europe Necrotic Enteritis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Necrotic Enteritis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Necrotic Enteritis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Necrotic Enteritis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Necrotic Enteritis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Necrotic Enteritis Treatment Market Facts & Figures by Country
3.7.1 Latin America Necrotic Enteritis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Necrotic Enteritis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Necrotic Enteritis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Necrotic Enteritis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Necrotic Enteritis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Necrotic Enteritis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Necrotic Enteritis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Necrotic Enteritis Treatment Sales by Type (2020-2031)
4.1.1 Global Necrotic Enteritis Treatment Sales by Type (2020-2025)
4.1.2 Global Necrotic Enteritis Treatment Sales by Type (2026-2031)
4.1.3 Global Necrotic Enteritis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Necrotic Enteritis Treatment Revenue by Type (2020-2031)
4.2.1 Global Necrotic Enteritis Treatment Revenue by Type (2020-2025)
4.2.2 Global Necrotic Enteritis Treatment Revenue by Type (2026-2031)
4.2.3 Global Necrotic Enteritis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Necrotic Enteritis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Necrotic Enteritis Treatment Sales by Application (2020-2031)
5.1.1 Global Necrotic Enteritis Treatment Sales by Application (2020-2025)
5.1.2 Global Necrotic Enteritis Treatment Sales by Application (2026-2031)
5.1.3 Global Necrotic Enteritis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Necrotic Enteritis Treatment Revenue by Application (2020-2031)
5.2.1 Global Necrotic Enteritis Treatment Revenue by Application (2020-2025)
5.2.2 Global Necrotic Enteritis Treatment Revenue by Application (2026-2031)
5.2.3 Global Necrotic Enteritis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Necrotic Enteritis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Prometic Life Sciences Inc.
6.1.1 Prometic Life Sciences Inc. Company Information
6.1.2 Prometic Life Sciences Inc. Description and Business Overview
6.1.3 Prometic Life Sciences Inc. Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Prometic Life Sciences Inc. Necrotic Enteritis Treatment Product Portfolio
6.1.5 Prometic Life Sciences Inc. Recent Developments/Updates
6.2 BioGaia Probiotics
6.2.1 BioGaia Probiotics Company Information
6.2.2 BioGaia Probiotics Description and Business Overview
6.2.3 BioGaia Probiotics Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioGaia Probiotics Necrotic Enteritis Treatment Product Portfolio
6.2.5 BioGaia Probiotics Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Company Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi AG Necrotic Enteritis Treatment Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Actavis Plc.
6.4.1 Actavis Plc. Company Information
6.4.2 Actavis Plc. Description and Business Overview
6.4.3 Actavis Plc. Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Actavis Plc. Necrotic Enteritis Treatment Product Portfolio
6.4.5 Actavis Plc. Recent Developments/Updates
6.5 Bayer International
6.5.1 Bayer International Company Information
6.5.2 Bayer International Description and Business Overview
6.5.3 Bayer International Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer International Necrotic Enteritis Treatment Product Portfolio
6.5.5 Bayer International Recent Developments/Updates
6.6 Alcon Laboratories, Inc.
6.6.1 Alcon Laboratories, Inc. Company Information
6.6.2 Alcon Laboratories, Inc. Description and Business Overview
6.6.3 Alcon Laboratories, Inc. Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alcon Laboratories, Inc. Necrotic Enteritis Treatment Product Portfolio
6.6.5 Alcon Laboratories, Inc. Recent Developments/Updates
6.7 Bausch & Lomb Incorporated
6.7.1 Bausch & Lomb Incorporated Company Information
6.7.2 Bausch & Lomb Incorporated Description and Business Overview
6.7.3 Bausch & Lomb Incorporated Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bausch & Lomb Incorporated Necrotic Enteritis Treatment Product Portfolio
6.7.5 Bausch & Lomb Incorporated Recent Developments/Updates
6.8 GlaxoSmithKline plc.
6.8.1 GlaxoSmithKline plc. Company Information
6.8.2 GlaxoSmithKline plc. Description and Business Overview
6.8.3 GlaxoSmithKline plc. Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline plc. Necrotic Enteritis Treatment Product Portfolio
6.8.5 GlaxoSmithKline plc. Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Necrotic Enteritis Treatment Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Transo-Pharm
6.10.1 Transo-Pharm Company Information
6.10.2 Transo-Pharm Description and Business Overview
6.10.3 Transo-Pharm Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Transo-Pharm Necrotic Enteritis Treatment Product Portfolio
6.10.5 Transo-Pharm Recent Developments/Updates
6.11 Rochem International
6.11.1 Rochem International Company Information
6.11.2 Rochem International Description and Business Overview
6.11.3 Rochem International Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rochem International Necrotic Enteritis Treatment Product Portfolio
6.11.5 Rochem International Recent Developments/Updates
6.12 HELM Portugal
6.12.1 HELM Portugal Company Information
6.12.2 HELM Portugal Description and Business Overview
6.12.3 HELM Portugal Necrotic Enteritis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 HELM Portugal Necrotic Enteritis Treatment Product Portfolio
6.12.5 HELM Portugal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Necrotic Enteritis Treatment Industry Chain Analysis
7.2 Necrotic Enteritis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Necrotic Enteritis Treatment Production Mode & Process Analysis
7.4 Necrotic Enteritis Treatment Sales and Marketing
7.4.1 Necrotic Enteritis Treatment Sales Channels
7.4.2 Necrotic Enteritis Treatment Distributors
7.5 Necrotic Enteritis Treatment Customer Analysis
8 Necrotic Enteritis Treatment Market Dynamics
8.1 Necrotic Enteritis Treatment Industry Trends
8.2 Necrotic Enteritis Treatment Market Drivers
8.3 Necrotic Enteritis Treatment Market Challenges
8.4 Necrotic Enteritis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ProMetic Life Sciences Inc
BioGaia Probiotics
Fresenius Kabi AG
Actavis
Bayer International
Alcon Laboratories， Inc
Bausch& Lomb Incorporated
GlaxoSmithKline PLC
Pfizer Inc
Transo-Pharm
Rochem International
HELM Portugal
List of Tables
 Table 1. Global Necrotic Enteritis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Necrotic Enteritis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Necrotic Enteritis Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Necrotic Enteritis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Necrotic Enteritis Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Necrotic Enteritis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Necrotic Enteritis Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Necrotic Enteritis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Necrotic Enteritis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Necrotic Enteritis Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Necrotic Enteritis Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Necrotic Enteritis Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Necrotic Enteritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotic Enteritis Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Necrotic Enteritis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Necrotic Enteritis Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Necrotic Enteritis Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Necrotic Enteritis Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Necrotic Enteritis Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Necrotic Enteritis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Necrotic Enteritis Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Necrotic Enteritis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Necrotic Enteritis Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Necrotic Enteritis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Necrotic Enteritis Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Necrotic Enteritis Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Necrotic Enteritis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Necrotic Enteritis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Necrotic Enteritis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Necrotic Enteritis Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Necrotic Enteritis Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Necrotic Enteritis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Necrotic Enteritis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Necrotic Enteritis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Necrotic Enteritis Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Necrotic Enteritis Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Necrotic Enteritis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Necrotic Enteritis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Necrotic Enteritis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Necrotic Enteritis Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Necrotic Enteritis Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Necrotic Enteritis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Necrotic Enteritis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Necrotic Enteritis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Necrotic Enteritis Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Necrotic Enteritis Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Necrotic Enteritis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Necrotic Enteritis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Necrotic Enteritis Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Necrotic Enteritis Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Necrotic Enteritis Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Necrotic Enteritis Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Necrotic Enteritis Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Necrotic Enteritis Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Necrotic Enteritis Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Necrotic Enteritis Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Necrotic Enteritis Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Necrotic Enteritis Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Necrotic Enteritis Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Necrotic Enteritis Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Necrotic Enteritis Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Necrotic Enteritis Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Necrotic Enteritis Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Necrotic Enteritis Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Necrotic Enteritis Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Necrotic Enteritis Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Necrotic Enteritis Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Necrotic Enteritis Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. Prometic Life Sciences Inc. Company Information
 Table 71. Prometic Life Sciences Inc. Description and Business Overview
 Table 72. Prometic Life Sciences Inc. Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Prometic Life Sciences Inc. Necrotic Enteritis Treatment Product
 Table 74. Prometic Life Sciences Inc. Recent Developments/Updates
 Table 75. BioGaia Probiotics Company Information
 Table 76. BioGaia Probiotics Description and Business Overview
 Table 77. BioGaia Probiotics Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BioGaia Probiotics Necrotic Enteritis Treatment Product
 Table 79. BioGaia Probiotics Recent Developments/Updates
 Table 80. Fresenius Kabi AG Company Information
 Table 81. Fresenius Kabi AG Description and Business Overview
 Table 82. Fresenius Kabi AG Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fresenius Kabi AG Necrotic Enteritis Treatment Product
 Table 84. Fresenius Kabi AG Recent Developments/Updates
 Table 85. Actavis Plc. Company Information
 Table 86. Actavis Plc. Description and Business Overview
 Table 87. Actavis Plc. Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Actavis Plc. Necrotic Enteritis Treatment Product
 Table 89. Actavis Plc. Recent Developments/Updates
 Table 90. Bayer International Company Information
 Table 91. Bayer International Description and Business Overview
 Table 92. Bayer International Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer International Necrotic Enteritis Treatment Product
 Table 94. Bayer International Recent Developments/Updates
 Table 95. Alcon Laboratories, Inc. Company Information
 Table 96. Alcon Laboratories, Inc. Description and Business Overview
 Table 97. Alcon Laboratories, Inc. Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Alcon Laboratories, Inc. Necrotic Enteritis Treatment Product
 Table 99. Alcon Laboratories, Inc. Recent Developments/Updates
 Table 100. Bausch & Lomb Incorporated Company Information
 Table 101. Bausch & Lomb Incorporated Description and Business Overview
 Table 102. Bausch & Lomb Incorporated Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bausch & Lomb Incorporated Necrotic Enteritis Treatment Product
 Table 104. Bausch & Lomb Incorporated Recent Developments/Updates
 Table 105. GlaxoSmithKline plc. Company Information
 Table 106. GlaxoSmithKline plc. Description and Business Overview
 Table 107. GlaxoSmithKline plc. Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline plc. Necrotic Enteritis Treatment Product
 Table 109. GlaxoSmithKline plc. Recent Developments/Updates
 Table 110. Pfizer Company Information
 Table 111. Pfizer Description and Business Overview
 Table 112. Pfizer Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Necrotic Enteritis Treatment Product
 Table 114. Pfizer Recent Developments/Updates
 Table 115. Transo-Pharm Company Information
 Table 116. Transo-Pharm Description and Business Overview
 Table 117. Transo-Pharm Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Transo-Pharm Necrotic Enteritis Treatment Product
 Table 119. Transo-Pharm Recent Developments/Updates
 Table 120. Rochem International Company Information
 Table 121. Rochem International Description and Business Overview
 Table 122. Rochem International Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Rochem International Necrotic Enteritis Treatment Product
 Table 124. Rochem International Recent Developments/Updates
 Table 125. HELM Portugal Company Information
 Table 126. HELM Portugal Description and Business Overview
 Table 127. HELM Portugal Necrotic Enteritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. HELM Portugal Necrotic Enteritis Treatment Product
 Table 129. HELM Portugal Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Necrotic Enteritis Treatment Distributors List
 Table 133. Necrotic Enteritis Treatment Customers List
 Table 134. Necrotic Enteritis Treatment Market Trends
 Table 135. Necrotic Enteritis Treatment Market Drivers
 Table 136. Necrotic Enteritis Treatment Market Challenges
 Table 137. Necrotic Enteritis Treatment Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Necrotic Enteritis Treatment
 Figure 2. Global Necrotic Enteritis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Necrotic Enteritis Treatment Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Parenteral Product Picture
 Figure 6. Global Necrotic Enteritis Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Necrotic Enteritis Treatment Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Home
 Figure 11. Global Necrotic Enteritis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Necrotic Enteritis Treatment Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Necrotic Enteritis Treatment Sales (2020-2031) & (K Units)
 Figure 14. Global Necrotic Enteritis Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 15. Necrotic Enteritis Treatment Report Years Considered
 Figure 16. Necrotic Enteritis Treatment Sales Share by Manufacturers in 2024
 Figure 17. Global Necrotic Enteritis Treatment Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Necrotic Enteritis Treatment Players: Market Share by Revenue in Necrotic Enteritis Treatment in 2024
 Figure 19. Necrotic Enteritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Necrotic Enteritis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Necrotic Enteritis Treatment Sales Market Share by Country (2020-2031)
 Figure 22. North America Necrotic Enteritis Treatment Revenue Market Share by Country (2020-2031)
 Figure 23. United States Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Necrotic Enteritis Treatment Sales Market Share by Country (2020-2031)
 Figure 26. Europe Necrotic Enteritis Treatment Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Necrotic Enteritis Treatment Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Necrotic Enteritis Treatment Revenue Market Share by Region (2020-2031)
 Figure 34. China Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Necrotic Enteritis Treatment Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Necrotic Enteritis Treatment Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Necrotic Enteritis Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Necrotic Enteritis Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Necrotic Enteritis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Necrotic Enteritis Treatment by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Necrotic Enteritis Treatment by Type (2020-2031)
 Figure 53. Global Necrotic Enteritis Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Necrotic Enteritis Treatment by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Necrotic Enteritis Treatment by Application (2020-2031)
 Figure 56. Global Necrotic Enteritis Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 57. Necrotic Enteritis Treatment Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Poultry Necrotic Enteritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Necrotic Enteritis Drug Market Insights Forecast to 2030
Global Necrotizing Skin infections Treatment Market Research Report 2024
Duck Virus Enteritis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pouchitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Enteric Viral Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Intestinal Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Necrotizing Fasciitis Drug Market Insights Forecast to 2030
Global Inflammatory Bowel Disease Therapy Market Insights Forecast to 2030
Enteric Parasite Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacterial Enteric Disease Testing Market Research Report 2024
Global Hirschsprung Disease Treatment Market Research Report 2025
Ulcerative Colitis Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Gut Health Solutions Market Research Report 2024
Global Peri implantitis Treatment Market Insights Forecast to 2030
Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Crohn s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hirschsprung Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diverticulitis Treatment Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions